The value of CYFRA 21-1, a new tumor marker, in nasopharyngeal carcinoma.

@article{Lin1998TheVO,
  title={The value of CYFRA 21-1, a new tumor marker, in nasopharyngeal carcinoma.},
  author={W. Y. Lin and Tzu-Chen Yen and King Yip Cheng and Shyh-Jen Wang},
  journal={Neoplasma},
  year={1998},
  volume={45 1},
  pages={21-4}
}
CYFRA 21-1 (CYFRA) is a newly-developed tumor marker which is useful in evaluating non-small cell lung carcinoma, especially the squamous cell type. The purpose of this study was to assess the clinical value of CYFRA in patients with nasopharyngeal carcinoma (NPC). Serum levels of CYFRA (CIS bio-International, France) were measured in 80 patients with untreated NPC. The histologic diagnosis of all patients was confirmed by biopsy. Twenty two (27.5%) of the tumors were classified as… CONTINUE READING